Clinical Trial Update: Using MSCs for Chronic Active Antibody Mediated Rejection [NA]

View source ↗

Summary

A clinical trial entry evaluating mesenchymal stem cell therapy for chronic active antibody-mediated rejection in kidney transplant recipients, currently not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Kidney Transplant Rejection | NA | Status: NOT_YET_RECRUITING